{
  "id": 7333159,
  "title": "Amgen: FDA Approves Update To IMDELLTRA Prescribing Information, Cuts Monitoring Time For Two Doses",
  "url": "https://urgent.news/2026/09/14/amgen-fda-approves-update-to-imdelltra-prescribing-information-cuts",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-14T13:22:40.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/amgen-fda-approves-update-imdelltra-prescribing-information-cuts-monitoring-time-two-doses"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Amgen (AMGN) announced the FDA approved an update to the IMDELLTRA Prescribing Information that substantially reduces the recommended monitoring time for the first two doses of treatment in an appropriate healthcare setting. This means that patients receiving IMDELLTR",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}